IE 11 is a very old Browser and it`s not supported on this site

Consolidated statement of cash flow for the year ended December 31

in CHF 1 000

 

Notes

 

2022

 

2021

Cash flows from operating activities

 

 

 

 

 

 

Proceeds from sales of securities

 

4

 

476 186

 

926 988

Purchase of securities

 

4

 

(200 687)

 

(962 091)

Interest receipts

 

 

 

4

 

Payments for services

 

 

 

(44 275)

 

(59 545)

Income taxes paid

 

 

 

(97)

 

(139)

Total cash flows from operating activities

 

 

 

231 131

 

(94 787)

 

 

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

 

Dividend

 

 

 

(212 242)

 

(199 440)

Proceeds from sales of treasury shares

 

7

 

 

9 653

Purchase of treasury shares

 

7

 

(27 303)

 

(9 459)

Borrowing of bank loans

 

5

 

8 000

 

292 000

Interest payments

 

 

 

(1 726)

 

(986)

Total cash flows from financing activities

 

 

 

(233 271)

 

91 768

 

 

 

 

 

 

 

Foreign exchange difference

 

 

 

1 253

 

(962)

Change in cash and cash equivalents

 

 

 

(887)

 

(3 981)

 

 

 

 

 

 

 

Cash and cash equivalents at the beginning of the period

 

 

 

2 835

 

6 816

 

 

 

 

 

 

 

Cash and cash equivalents at the end of the period

 

 

 

1 948

 

2 835

The notes are an integral part of the consolidated financial statements.

BB Biotech AG uses cookies to improve website usability and ensure the best possible user experience. Use of cookies & disclaimer